Geode Capital Management’s Aptose Biosciences, Inc. APTO Stock Holding History

Geode Capital Management’s Portfolio APTO Stock Details APTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-72	Closed	-$20.8K	–	4825
2023 Q1	$20.8K	Hold	72	–	–	﹤0.01%	4697
2022 Q4	$18K	Hold	72	–	–	﹤0.01%	4784
2022 Q3	$19K	Hold	72	–	–	﹤0.01%	4927
2022 Q2	$24K	Hold	72	–	–	﹤0.01%	4901
2022 Q1	$44K	Hold	72	–	–	﹤0.01%	4829
2021 Q4	$43K	Hold	72	–	–	﹤0.01%	4887
2021 Q3	$70K	Sell	72 -59	-45%	-$73.8K	﹤0.01%	4740
2021 Q2	$195K	Hold	131	–	–	﹤0.01%	4352
2021 Q1	$352K	Hold	131	–	–	﹤0.01%	3934
2020 Q4	$258K	Buy	131 +29	+28%	+$68.1K	﹤0.01%	3806
2020 Q3	$274K	Hold	102	–	–	﹤0.01%	3621
2020 Q2	$288K	Hold	102	–	–	﹤0.01%	3555
2020 Q1	$271K	Buy	102 +30	+42%	+$89.5K	﹤0.01%	3458
2019 Q4	$184K	Hold	72	–	–	﹤0.01%	3822
2019 Q3	$67K	Hold	72	–	–	﹤0.01%	4027
2019 Q2	$84K	Buy	72 +33	+85%	+$30.4K	﹤0.01%	3994
2019 Q1	$35K	Hold	39	–	–	﹤0.01%	4058
2018 Q4	$33K	Buy	+39	New	+$38.4K	﹤0.01%	4050

Other funds holding APTO

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Geode Capital Management's APTO Position: Q2 2023 in Review

Geode Capital Management sold out of Aptose Biosciences, Inc. (APTO) in Q2 2023, closing a stake of 72 shares — an estimated $20.8K sold.

Geode Capital Management first reported a position in APTO in Q4 2018 and held it in 18 quarters. The position peaked at $352K in Q1 2021. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.

Geode Capital Management reported no remaining Aptose Biosciences, Inc. position as of Q2 2023 after selling out during the quarter.
Geode Capital Management sold 72 Aptose Biosciences, Inc. shares in Q2 2023, an estimated $20.8K.
Geode Capital Management first reported a position in Aptose Biosciences, Inc. in Q4 2018 and held it in 18 quarters.
Geode Capital Management's Aptose Biosciences, Inc. position peaked at $352K in Q1 2021.
24 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q2 2023.

Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.